Your browser doesn't support javascript.
loading
Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria.
Erameh, Cyril; Edeawe, Osahogie; Akhideno, Peter; Eifediyi, Gloria; Omansen, Till F; Wagner, Christine; Sarpong, Francisca; Koch, Till; Wicha, Sebastian; Kurth, Florian; Duraffour, Sophie; Oestereich, Lisa; Pahlmann, Meike; Okogbenin, Sylvanus; Ogbaini-Emovon, Ephraim; Günther, Stephan; Ramharter, Michael; Groger, Mirjam.
Afiliação
  • Erameh C; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Edeawe O; Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Akhideno P; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Eifediyi G; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Omansen TF; Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Wagner C; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Sarpong F; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Koch T; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wicha S; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kurth F; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Duraffour S; Department of Clinical Pharmacology, University of Hamburg, Hamburg, Germany.
  • Oestereich L; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pahlmann M; Department of Infectious Diseases and Pulmonary Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Okogbenin S; Department of Virology, Bernhard-Nocht-Institut fur Tropenmedizin, Hamburg, Germany.
  • Ogbaini-Emovon E; Department of Virology, Bernhard-Nocht-Institut fur Tropenmedizin, Hamburg, Germany.
  • Günther S; Department of Virology, Bernhard-Nocht-Institut fur Tropenmedizin, Hamburg, Germany.
  • Ramharter M; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Groger M; Department of Obstetrics and Gynaecology, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
BMJ Open ; 10(4): e036936, 2020 04 16.
Article em En | MEDLINE | ID: mdl-32303517

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Ribavirina / Febre Lassa Tipo de estudo: Guideline / Observational_studies Limite: Adult / Humans País como assunto: Africa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Ribavirina / Febre Lassa Tipo de estudo: Guideline / Observational_studies Limite: Adult / Humans País como assunto: Africa Idioma: En Ano de publicação: 2020 Tipo de documento: Article